arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Protalix BioTherapeutics, Inc.

PLX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$2.55
▼ -0.8% Today
as of Oct 23, 16:51 ET
Last 30 days -7.94% Sep 14 → Oct 23
$2.53 $2.61 $2.69 $2.78 $2.86 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$2.54
High
$2.56
Low
$2.50
Volume
$383,906
Avg Vol
$850,664
Mkt Cap
$216M
P/E (TTM)
8.73
Beta
—
52w High
$3.19
52w Low
$1.65
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 1 item

Sep 8 · 10:45 PR PR Newswire
Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences

PLX earnings at a glance

The options market is pricing a move of about ±25.8% after the report, a range of roughly $1.89 to $3.21 from today's $2.55. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±20.8% on average; after the most recent report on May 13, 2026 it moved +1.0%. That means options currently expect more movement than PLX has typically delivered. PLX beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 206%. The share price of $2.55 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.65
$3.19
58% of range
Avg surprise (last 4)
+496.9%
Avg reaction (last 2)
-19.7%
50% positive
Latest IV / EM
206%
EM ±25.8% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.06$0.01$0.08$0.15$0.22 Actual $-0.05Actual $0.21Actual $-0.04Actual $-0.06Actual $-0.03Actual $0.03Actual $-0.05Est $0.08Est $0.03Actual $0.03Est $0.06Actual $0.22Est $-0.01Actual $0.05 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-4M$6M$16M$26M$35M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.05 — — — — financials
Wed May 13, 2026Mar/2026 $0.22 $-0.01 +2,300% +540.0% +1.0% earnings
Thu Nov 13, 2025Sep/2025 $0.03 $0.06 -50.0% — — earnings
Thu Aug 14, 2025Jun/2025 — $0.03 -100.0% — — earnings
Fri May 9, 2025Mar/2025 $-0.05 $0.08 -162.5% — -40.5% earnings
Mon Sep 30, 2024Sep 2024 $0.03 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.03 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.06 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.04 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.21 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.05 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$20M$34M—$18M$16M$10M—$18M
Cost of revenue$8M$4M—$8M$6M$8M—$8M
Gross profit————————
Operating income$5M$21M—$2M$1M$-4M—$4M
Net income$4M$18M—$2M$164,000$-4M—$3M
EPS (diluted)$0.05$0.22—$0.03—$-0.05—$0.03

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$27M$41M$15M$14M$18M$19M$20M$27M
Inventory$32M$30M$26M$21M$21M$20M$21M$17M
Total current assets$92M$86M$67M$67M$65M$61M$60M$48M
Total assets$110M$102M$82M$82M$78M$74M$73M$62M
Long-term debt————————
Total liabilities$39M$35M$34M$29M$29M$29M$30M$29M
Total equity$71M$67M$48M$53M$50M$45M$43M$32M

Implied volatility — last 90 days

33%202%371%540%709% Jun 07 — IV 200% · EM ±27.6%Jun 08 — IV 215% · EM ±28.3%Jun 09 — IV 242% · EM ±30.3%Jun 10 — IV 344% · EM ±40.6%Jun 11 — IV 132% · EM ±14.6%Jun 12 — IV 257% · EM ±26.3%Jun 19 — IV 194% · EM ±42.8%Jun 22 — IV 33% · EM ±6.9%Jun 23 — IV 46% · EM ±9.4%Jun 24 — IV 111% · EM ±22.3%Jun 25 — IV 34% · EM ±6.8%Jun 26 — IV 34% · EM ±6.5%Jun 29 — IV 36% · EM ±6.3%Jun 30 — IV 37% · EM ±6.4%Jul 01 — IV 52% · EM ±8.7%Jul 02 — IV 93% · EM ±15.1%Jul 03 — IV 97% · EM ±15.1%Jul 06 — IV 47% · EM ±6.5%Jul 07 — IV 48% · EM ±6.4%Jul 08 — IV 50% · EM ±6.3%Jul 09 — IV 54% · EM ±6.3%Jul 10 — IV 56% · EM ±6.1%Jul 13 — IV 125% · EM ±10.5%Jul 20 — IV 61% · EM ±14.5%Jul 21 — IV 55% · EM ±12.7%Jul 22 — IV 37% · EM ±8.4%Jul 23 — IV 47% · EM ±10.5%Jul 24 — IV 67% · EM ±14.8%Jul 27 — IV 50% · EM ±10.4%Jul 28 — IV 52% · EM ±10.7%Jul 29 — IV 55% · EM ±11.0%Jul 30 — IV 146% · EM ±28.6%Jul 31 — IV 44% · EM ±8.4%Aug 03 — IV 61% · EM ±10.8%Aug 04 — IV 61% · EM ±10.5%Aug 05 — IV 72% · EM ±12.1%Aug 06 — IV 76% · EM ±12.3%Aug 07 — IV 52% · EM ±8.1%Aug 10 — IV 73% · EM ±10.1%Aug 11 — IV 78% · EM ±10.3%Aug 12 — IV 122% · EM ±15.3%Aug 13 — IV 53% · EM ±6.2%Aug 14 — IV 224% · EM ±24.8%Aug 26 — IV 40% · EM ±8.1%Aug 27 — IV 68% · EM ±13.4%Aug 28 — IV 62% · EM ±11.8%Aug 31 — IV 66% · EM ±11.7%Sep 01 — IV 78% · EM ±13.5%Sep 02 — IV 231% · EM ±38.6%Sep 03 — IV 106% · EM ±17.2%Sep 04 — IV 120% · EM ±18.7%Sep 07 — IV 135% · EM ±18.7%Sep 08 — IV 86% · EM ±11.3%Sep 09 — IV 135% · EM ±16.9%Sep 10 — IV 155% · EM ±18.3%Sep 11 — IV 137% · EM ±15.2%Sep 14 — IV 173% · EM ±14.4%Sep 15 — IV 390% · EM ±28.2%Sep 16 — IV 158% · EM ±9.3%Sep 17 — IV 709% · EM ±29.6%Sep 21 — IV 113% · EM ±23.6%Sep 22 — IV 146% · EM ±29.9%Sep 24 — IV 111% · EM ±21.8%Sep 25 — IV 115% · EM ±22.1%Oct 01 — IV 127% · EM ±20.5%Oct 02 — IV 165% · EM ±25.8%Oct 05 — IV 182% · EM ±25.2%Oct 07 — IV 206% · EM ±25.8%

Sector peers

IVVD
Invivyd, Inc.
$215M $0.61-4.0%
ALEC
Alector, Inc.
$214M $1.83-2.1%
CGEN
Compugen Ltd.
$221M $1.94-8.5%
IPHA
Innate Pharma S.A.
$208M $1.50-4.5%
LCTX
Lineage Cell Therapeutics, Inc.
$240M $1.00+5.3%
CRDL
Cardiol Therapeutics Inc.
$189M $1.12-4.3%

PLX earnings FAQ

What is PLX's expected move for earnings?

Options currently price a move of about ±25.8%, or $0.66 per share either way from $2.55.

How does PLX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±20.8%, up 1 times and down 1 times.

What is PLX's implied volatility?

PLX's at-the-money implied volatility is about 206% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in